Influenza
A(H7N9) has infected more than 130 people in the People’s Republic
of China. It is a severe disease; more than 40 individuals have died.
Those individuals that do survive often require long hospital stays
including many days in an intensive care unit (ICU). Hospitalization
in ICUs is expensive.
For
example, the first A(H7N9) case from Guangdong Province, spent 20
days in ICU, with the hospital costs totaling about 220,000
yuan [1]. In China, the average annual wage is 42,000 yuan.[2]
Putting the hospitalization cost for A(H7N9) for this patient in
perspective, it would take an average individual in China more than
five years to pay off this cost providing 100% of the salary went to
pay the hospital bill.
This
individual is not an isolated case. Based on limited publicly
available data, 28 of the individuals infected with A(H7N9) from China who recovered were
hospitalized between 6-30+ days, with a median hospital stay of 18
days, although not all of them were treated in the ICU. Information is available on 23 of the individuals in China who
died from A(H7N9). These 23 individuals were treated in the
hospital between 2-30+ days before death, with a median hospital stay
of 11 days among these individuals who died. What these statistics
indicate is that extended hospital treatment is required for most
A(H7N9) patients, up to 30 days with no guarantee of recovery.
These data also suggest the extraordinary costs being absorbed by
Chinese government to treat these infected individuals.
Comparison
with the USA
In
an article published in 2012 in the Annals of Intensive Care, the
authors studied the total hospitalization cost for various categories
of patients including 23 Influenza A(H1N1)pdm09 patients from
Cleveland, Ohio.[3] The total hospital costs in Cleveland in
2009-2010 for treating influenza patients in intensive care units
averaged about $342,000, about 6.5 times the median annual
household income ($52,700) in the USA.[4]
ICU
care is comparatively expensive both in China and the US and is
primarily related to occurrence of acute respiratory distress
syndrome (ARDS). ARDS is among the most expensive conditions
encountered in the ICU. [4] ARDS is also a common
occurrence in individuals infect with novel influenza A(H5N1) and
A(H7N9). In fact, a recent study of A(H7N9) patients from
Zhejiang Province in China showed that 100% of the cases had
complications from ARDS.[5]
If
a novel influenza pandemic breaks out, many sick individuals will
require extended hospital care in ICUs. The cost of this care to
governments and health insurance companies will be enormous. The more
ominous concern is that if a new influenza pandemic occurs, there
will simply not be enough medical facilities to care for all the
individuals that may need hospitalization regardless of whether an
individual can pay or not.
[1] Guangdong's
first H7N9 patient can be discharged next week, nearly 220,000 yuan
treatment fee h/t Pathfinder
[2] Average
wages in China
[3]
Relative
cost and outcomes in the intensive care unit of acute lung injury
(ALI) due to pandemic influenza compared with other etiologies: a
single-center study
[4] US
Census Bureau Quick Facts
[5]
Epidemiological,
clinical and viral characteristics of fatal cases of human avian
influenza A (H7N9) virus in Zhejiang Province, China